When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat ...

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, ...

Clinical data from the OT‑101 P001 PDAC study suggest targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...

When & Where: Shadow Summit – Monday, July 21 from 10 a.m. to 4:30 p.m. Hidden Valley Resort (next door to the Deerhurst Resort where the Premiers are meeting) 1755 Valley Rd, Huntsville, ON P1H 1A8 ...

This insider transaction follows prior purchases by other members of the board and the new leadership team and reflects growing alignment and confidence in the Company’s operational progress. Hapbee ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the ...

Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of ...

The RSU awards and stock options were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635 (c) (4) under the ...

Clinical data from the OT‑101 P001 PDAC study suggest that targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call ...

CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its ...